Dr. Naeve was most recently an independent consultant assisting early stage life science companies in the San Diego region. Greg was previously the President and Chief Scientific Officer of Parallax Biosystems, a company he co-founded to develop novel molecular detection platforms with applications in pre-clinical drug discovery and diagnostics. Prior to Parallax he held positions at Neurocrine Biosciences and Amgen, working to develop new therapies for neurodegenerative disorders. He received his Ph.D. in Biochemistry from the University of Southern California.